Filed before 2025Filed 24 January 2012
Inviragen, Inc. has sold $15.3M so far
Inviragen, Inc., a biotech company based in Fort Collins, CO, has sold $15.3M so far in its equity round, according to a filing dated 24 January 2012.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 24 January 2012
- Round
- Equity round (amended filing)
- Amount sold
- $15.3M
- Offering size
- $15.3M
- Investors so far
- 24
- Based in
- Fort Collins, CO
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 82% of the 368 tracked raises with an amount filed in 2012, and than 84% of the 32 in biotech.
Inviragen, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 24 Jan 2012 | Amended filing | $15.3M | This raise |
More with Venture Investors Health on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.